Stock AB AB SCIENCE
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AB Science

Equities

AB

FR0010557264

Market Closed - Euronext Paris
Other stock markets
 11:35:15 2024-04-26 am EDT 		5-day change 1st Jan Change
1.936 EUR +2.76% Intraday chart for AB Science -1.63% -45.54%
Apr. 04 AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada MT
Apr. 03 AB Science: reconsideration possible for masitinib in ALS CF

Evolution of the average Target Price on AB Science

Price target over the last 5 years

History of analyst recommendation changes

70.oSJS7rlGu1y4PuotLzwZiUO7x5lat1n_wWZqLGiVnhI.w30Yqc4s4xLhcIYeQFhtuXTYrs4Lwh7Jtz85QibtzXvUQAWP4w7aEIxMrw~c14f4da128cb26f57f94ab4d27131e72

Analyst Recommendations on AB Science

AB Science : Masitinib Treatment Against Pancreatic Cancer Boosts Survival Rates MT
SCIENCE : AB Science: Chardan Capital Markets initiates coverage with a BUY recommendation on AB Science and a target price of €30 GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.936 EUR
Average target price
6.895 EUR
Spread / Average Target
+256.15%
High Price Target
10 EUR
Spread / Highest target
+416.53%
Low Price Target
3.79 EUR
Spread / Lowest Target
+95.76%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AB Stock
  4. Consensus AB Science